Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|September 26, 2019
The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic PlasticityHayley R Walsh, Brianne M Cruickshank, Justin M Brown, et al.
Cell Death and Differentiation|June 15, 2019
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cellsDejan Vidovic, Thomas T Huynh, Prathyusha Konda, et al.
Scientific Reports|July 3, 2019
Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cellsThomas T Huynh, Mohammad Sultan, Dejan Vidovic, et al.
Cancers|June 2, 2021
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast CancerBrianne M Cruickshank, Marie-Claire D Wasson, Justin M Brown, et al.
Molecular Oncology|May 1, 2021
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancerMohammad Sultan, Jacob T Nearing, Justin M Brown, et al.
Molecular Cancer Therapeutics|March 12, 2020
Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug ResistanceMargaret L Dahn, Brianne M Cruickshank, Ainsleigh J Jackson, et al.
Stem Cells (Dayton, Ohio)|January 18, 2018
Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune EvasionMohammad Sultan, Dejan Vidovic, Arianne S Paine, et al.
Oncogene|September 9, 2024
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancerWasundara Fernando, Brianne M Cruickshank, Raj Pranap Arun, et al.
Molecular Oncology|September 27, 2023
ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathwayAlamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, et al.
Biomarker Research|October 29, 2025
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.
Pageof 1